Xencor, Inc. (XNCR) Q1 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Xencor, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.807 -- 00:00:02.749 Good afternoon, and thank you for standing by. 00:00:02.749 -- 00:00:07.831 Welcome to Zencore's first quarter 2023 conference. 00:00:08.114 -- 00:00:09.975 All participants are in a listen-only mode. 00:00:09.975 -- 00:00:14.599 After the speaker's presentation, there will be a question-and-answer session. 00:00:14.599 -- 00:00:18.823 Please be advised that this call is going to be recorded at the company's request. 00:00:18.823 -- 00:00:22.586 Now, I would like to turn the call over to your speaker today, Charles Lillies from the 00:00:22.586 -- 00:00:25.169 Head of Corporate Communications and Investor Relations. 00:00:25.169 -- 00:00:27.489 Go ahead, Charles. 00:00:27.651 -- 00:00:31.608 Thank you, and good afternoon. Earlier today, we issued a press release with outlines 00:00:31.608 -- 00:00:36.471 of the topics we plan to discuss today. It's available at www.cencor.com. 00:00:36.733 -- 00:00:40.297 Providing abbreviated comments on the call is Basil Dekiat, President and Chief Executive 00:00:40.297 -- 00:00:43.861 Officer. Afterward, we will open up the call for your questions, and we will be joined 00:00:43.861 -- 00:00:48.206 by Alan Yang, Chief Medical Officer, John Desjarlais, Chief Scientific Officer, John 00:00:48.206 -- 00:00:52.782 Cush, Chief Financial Officer, as well as Nancy Valenti, Chief Development Officer. 00:00:52.782 -- 00:00:55.366 Before we begin, I would like to remind you that during the course of this conference 00:00:55.366 -- 00:00:58.631 call, Zencore Management may make forward-looking statements, including statements regarding 00:00:58.631 -- 00:01:01.976 the company's future financial and operating results, future market conditions, plans 00:01:01.976 -- 00:01:05.961 and objectives of management...